ResoundingHealth
Search
  
Basic Drug Info
Drug Name:Fluocinonide
Manufacturer:E. FOUGERA and CO.
Other Info:

Pregnancy Category C: Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels.

The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals.

There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids.

Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.



Clinical Trials:


Indications and Usage
Fluocinonide Cream USP, 0.05% (Emollient Base) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dermatologic disorders -- impairment of health or a condition of abnormal functioning of the skin.

Contraindications
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

Branded Drugs
The following US Branded drugs contain Fluocinonide


FLUOCINONIDE EMULSIFIED BASE -- ACTAVIS MID ATLANTIC LLC

FLUOCINONIDE EMULSIFIED BASE -- ALTANA INC

FLUOCINONIDE EMULSIFIED BASE -- TARO PHARMACEUTICALS USA INC

FLUOCINONIDE EMULSIFIED BASE -- TEVA PHARMACEUTICALS USA INC

LIDEX -- MEDICIS PHARMACEUTICAL CORP

LIDEX-E -- MEDICIS PHARMACEUTICAL CORP

VANOS -- MEDICIS PHARMACEUTICAL CORP


This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.